Searched for
VANCOMYCIN
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...- NPPA revises ceiling prices of 128 formulationsThe National Pharmaceutical Pricing Authority (NPPA) has also fixed the retail price of 12 scheduled formulations under Drugs (Prices Contr...
- Aurobindo Pharma gets final USFDA nod for anti-viral drugAurobindo Pharma has received final approval from the US health regulator to manufacture and market anti-viral Valganciclovir tablets in th...
- Aurobindo Pharma gets USFDA nod for antibiotic drugAurobindo Pharma has received final approval from the US health regulator to market its generic antibiotic drug Vancomycin Hydrochloride fo...
- Government caps price of 18 formulation packsAs per the notification, the prices of formulations including Diclofenac Sodium, Clotrimazole, Mesalamine, Omeprazole+Domperidone and Vanco...
- Humans carry more superbugs than farm animals, says new studyHumans carry more antibiotic-resistant bacteria than the farm animals they handle, a new study on dairy farmers has found.
- Three weapons to slow down bacteria spread in hospitalsBeing a scientist, Jayant Halder has just three kinds of weapons: a new drug, a method to tweak old drugs, and a paint that can slow down t...
- Lupin gets USFDA approval for diarrhoea drugLupin Pharmaceuticals Inc (LPI), the company's US subsidiary would commence marketing the product shortly.
- Venus Remedies gets additional US patent nod for VancoplusDrug firm Venus Remedies received additional patent approval from USPTO for its product 'Vancoplus', used for treating bacterial infections.
- Silver can make antibiotics more effectiveSilver added to antibiotics could make them 10 to 1,000 times more effective and enable them to fight drug-resistant infections
- Strides Arcolab gets USFDA nod for its generic anti-bacterial capsulesStrides Arcolab plans to immediately launch the product through US-headquartered firm Alvogen on a profit sharing basis.
- Venus Remedies gets Australian patent approval for VancoplusDrug firm Venus Remedies today said it has received approval from the Australian Patent office (APO) for its product 'Vancoplus'.
- Strides Arcolab Q4 net profit up 4.54%; stock downDrug firm Strides Arcolab today said its consolidated net profit rose by 4.54 per cent to Rs 45.08 crore for the first quarter ended March ...
- Strides Arcolab Q4 net profit up 4.54% to Rs 45.08 croreDrug firm Strides Arcolab today said its consolidated net profit rose by 4.54 per cent to Rs 45.08 crore for the first quarter ended March ...
- Strides Arcolab gets USFDA nod for Bangalore unit's productDrug firm Strides Arcolab today said it has received US health regulator's approval to market a product from its new facility in Karnataka.
- Biocon's drug development partner Optimer receives US patent for FidaxomicinThe closest competitor for Fidaxomicin is vancomycin - an antibiotec injectable manufactured and supplied by Strides Arcolabs.
- Strides acquires Diaspa's fermentation unitPharmaceutical company Strides Arcolab today said it has completed the acquisition of Italy-based Diaspa SpA's fermentation assets includin...
- Strides Arcolab completes Diaspa buyDiaspa has a fermentation capacity of 925 cubic meters and produces a range of niche pharmaceuticals.
- Nicholas Piramal gets FDA okay for cancer drug trialsNicholas Piramal announced on Monday that it had received approval from the USFDA to start clinical trials on humans for its new cancer dru...
- Wockhardt in talks to out-license research moleculesWockhardt is likely to out-license some of its research molecules to global pharma companies.
Load More
